Advisors Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $19M | Buy |
87,244
+6,872
| +9% | +$1.52M | 0.32% | 52 |
|
|
2025
Q4 | $18.4M | Buy |
80,372
+8,286
| +11% | +$1.89M | 0.31% | 51 |
|
|
2025
Q3 | $16.7M | Sell |
72,086
-2,005
| -3% | -$408K | 0.28% | 56 |
|
|
2025
Q2 | $13.8M | Sell |
74,091
-2,840
| -4% | -$528K | 0.25% | 70 |
|
|
2025
Q1 | $16.1M | Sell |
76,931
-22,373
| -23% | -$4.35M | 0.3% | 51 |
|
|
2024
Q4 | $17.6M | Sell |
99,304
-40,794
| -29% | -$7.5M | 0.33% | 50 |
|
|
2024
Q3 | $27.7M | Sell |
140,098
-39,044
| -22% | -$7.29M | 0.51% | 28 |
|
|
2024
Q2 | $30.7M | Sell |
179,142
-38,077
| -18% | -$6.31M | 0.6% | 21 |
|
|
2024
Q1 | $39.6M | Sell |
217,219
-36,274
| -14% | -$6.25M | 0.76% | 13 |
|
|
2023
Q4 | $39.3M | Sell |
253,493
-25,482
| -9% | -$3.72M | 0.8% | 12 |
|
|
2023
Q3 | $41.6M | Sell |
278,975
-7,464
| -3% | -$1.1M | 0.9% | 13 |
|
|
2023
Q2 | $38.6M | Sell |
286,439
-11,799
| -4% | -$1.73M | 0.79% | 15 |
|
|
2023
Q1 | $47.5M | Buy |
298,238
+4,561
| +2% | +$697K | 0.97% | 10 |
|
|
2022
Q4 | $47.5M | Sell |
293,677
-4,119
| -1% | -$632K | 0.98% | 10 |
|
|
2022
Q3 | $40M | Sell |
297,796
-2,113
| -0.7% | -$303K | 0.84% | 12 |
|
|
2022
Q2 | $45.9M | Sell |
299,909
-13,366
| -4% | -$2.04M | 0.87% | 14 |
|
|
2022
Q1 | $50.8M | Sell |
313,275
-8,384
| -3% | -$1.22M | 0.78% | 12 |
|
|
2021
Q4 | $43.6M | Buy |
321,659
+11,090
| +4% | +$1.31M | 0.62% | 23 |
|
|
2021
Q3 | $33.5M | Buy |
310,569
+22,764
| +8% | +$2.6M | 0.51% | 29 |
|
|
2021
Q2 | $32.4M | Buy |
287,805
+21,794
| +8% | +$2.45M | 0.48% | 29 |
|
|
2021
Q1 | $28.8M | Buy |
266,011
+30,762
| +13% | +$3.29M | 0.45% | 32 |
|
|
2020
Q4 | $25.2M | Buy |
235,249
+17,268
| +8% | +$1.66M | 0.42% | 38 |
|
|
2020
Q3 | $19.1M | Sell |
217,981
-5,191
| -2% | -$489K | 0.35% | 46 |
|
|
2020
Q2 | $21.9M | Sell |
223,172
-7,921
| -3% | -$697K | 0.43% | 35 |
|
|
2020
Q1 | $17.6M | Sell |
231,093
-33,166
| -13% | -$2.82M | 0.42% | 43 |
|
|
2019
Q4 | $23.4M | Sell |
264,259
-34,076
| -11% | -$2.83M | 0.41% | 39 |
|
|
2019
Q3 | $22.6M | Buy |
298,335
+10,912
| +4% | +$748K | 0.42% | 38 |
|
|
2019
Q2 | $20.9M | Buy |
287,423
+16,940
| +6% | +$1.33M | 0.38% | 52 |
|
|
2019
Q1 | $21.8M | Buy |
270,483
+16,991
| +7% | +$1.39M | 0.39% | 47 |
|
|
2018
Q4 | $22.8M | Buy |
253,492
+498
| +0.2% | +$43.8K | 0.46% | 32 |
|
|
2018
Q3 | $23.9M | Sell |
252,994
-21,389
| -8% | -$2.03M | 0.39% | 43 |
|
|
2018
Q2 | $25.4M | Sell |
274,383
-170,102
| -38% | -$16.6M | 0.43% | 34 |
|
|
2018
Q1 | $51.3M | Sell |
444,485
-12,242
| -3% | -$1.34M | 0.86% | 9 |
|
|
2017
Q4 | $44.2M | Sell |
456,727
-72,265
| -14% | -$6.81M | 0.73% | 9 |
|
|
2017
Q3 | $47M | Sell |
528,992
-56,881
| -10% | -$4.33M | 0.79% | 9 |
|
|
2017
Q2 | $42.5M | Sell |
585,873
-26,891
| -4% | -$1.81M | 0.71% | 10 |
|
|
2017
Q1 | $39.9M | Sell |
612,764
-13,004
| -2% | -$818K | 0.67% | 10 |
|
|
2016
Q4 | $39.2M | Buy |
625,768
+1,524
| +0.2% | +$93K | 0.65% | 8 |
|
|
2016
Q3 | $39.4M | Buy |
624,244
+85,278
| +16% | +$5.52M | 0.65% | 8 |
|
|
2016
Q2 | $33.4M | Sell |
538,966
-31,524
| -6% | -$1.92M | 0.54% | 12 |
|
|
2016
Q1 | $32.6M | Buy |
570,490
+87,868
| +18% | +$4.9M | 0.54% | 14 |
|
|
2015
Q4 | $28.6M | Sell |
482,622
-42,057
| -8% | -$2.42M | 0.45% | 28 |
|
|
2015
Q3 | $28.5M | Buy |
524,679
+55,494
| +12% | +$3.61M | 0.46% | 27 |
|
|
2015
Q2 | $31.5M | Sell |
469,185
-43,874
| -9% | -$2.86M | 0.43% | 40 |
|
|
2015
Q1 | $30M | Buy |
513,059
+85,500
| +20% | +$5.17M | 0.4% | 56 |
|
|
2014
Q4 | $28M | Buy |
427,559
+63,534
| +17% | +$4.01M | 0.38% | 63 |
|
|
2014
Q3 | $21M | Buy |
364,025
+128,158
| +54% | +$7.12M | 0.29% | 94 |
|
|
2014
Q2 | $13.3M | Buy |
235,867
+100,110
| +74% | +$5.25M | 0.18% | 153 |
|
|
2014
Q1 | $6.98M | Buy |
135,757
+79,515
| +141% | +$4.02M | 0.11% | 243 |
|
|
2013
Q4 | $2.97M | Sell |
56,242
-6,323
| -10% | -$311K | 0.05% | 427 |
|
|
2013
Q3 | $2.8M | Sell |
62,565
-13,370
| -18% | -$593K | 0.05% | 415 |
|
|
2013
Q2 | $3.14M | Buy |
+75,935
| New | +$3.32M | 0.06% | 374 |
|
Other funds holding ABBV
VCM
VPM
Advisors Asset Management's ABBV Position: Q1 2026 in Review
Advisors Asset Management increased its AbbVie (ABBV) stake by 8.6% in Q1 2026, buying an estimated $1.52M and bringing the position to 87,244 shares worth $19M. The position accounts for 0.32% of the portfolio, ranked #52.
Advisors Asset Management first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $51.3M in Q1 2018. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Advisors Asset Management held 87,244 shares of AbbVie worth $19M as of Q1 2026.
- Advisors Asset Management bought 6,872 AbbVie shares in Q1 2026, an estimated $1.52M.
- AbbVie made up 0.32% of Advisors Asset Management's portfolio in Q1 2026, its #52 holding.
- Advisors Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Advisors Asset Management's AbbVie position peaked at $51.3M in Q1 2018.
- 4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Advisors Asset Management's 13F filing for Q1 2026, filed 15 May 2026.